Letter From the Editor: Planning for Retirement

As physicians, we cannot help but plan for the future. In fact, our very careers are built on the promise of delayed gratification. While our […]

Letter From the Editor: Helping More Smokers to Quit

Lung cancer is currently the second most common cancer in the United States, with an estimated 228,150 new cases and 142,670 deaths in 2019, according […]

Letter From the Editor: A Noble Nobel

I was seeing patients in clinic on October 7th when I learned that the 2019 Nobel Prize in Physiology or Medicine had been awarded to Dr […]

Letter From the Editor: How Biosimilars Affect Health Care

This issue of Clinical Advances in Hematology & Oncology features an interview with Dr Gary H. Lyman about a topic in health care that is increasingly […]

Letter From the Editor: Counting Stars

While returning home on a transatlantic flight and stuck in a middle seat, sandwiched between a movie watcher and a sleeper, I pondered the fact that […]

Letter from the Editor: Precise vs Imprecise Medicine

This issue of Clinical Advances in Hematology & Oncology includes articles that demonstrate how two opposite approaches to cancer therapy can be correct. I believe […]

Letter From the Editor: Caring for Every Patient, Learning From Every Patient

Every year, ASCO has a theme for its annual meeting, something to define the most impactful presentations and the state of oncology. In past years, […]

Letter From the Editor: The Median Isn’t the Message

In his letter last month, Dr Daniel George discussed the term “outcomes” in oncology research and how it applies to patients. One impression I was […]

Letter From the Editor: Outcomes

Outcomes: it’s a buzzword in medicine these days. Outcomes research. Patient-reported outcomes. Health-related outcomes. Plenty of terminology is focused on this word, but what does […]

Letter From the Editor: Building a Better FDA

This March, the physician Scott Gottlieb resigned from his post as commissioner of the FDA to spend more time with his family. Dr Gottlieb’s appointment, […]

Letter From the Editor: Talk to Me

Medical communication is increasingly nonverbal. Electronic medical records, e-mail, texting, websites, search engines, and even social media all make us depend less than ever on the […]

Letter From the Editor: Clinical Advances: Past and Present

This issue kicks off the 17th year of publication of Clinical Advances in Hematology & Oncology, with more than 2000 articles now listed in PubMed. […]

Letter From the Editor: With a Little Help From My Friends

My two-year tenure as Editor-in-Chief ends with this issue. I was struggling a bit with a topic for this month’s letter, until I read an article […]

Letter From the Editor: On RELEVANCE

Many effective treatment options exist for follicular lymphoma. Patients with low tumor burden can be managed initially with deferral of therapy (watch and wait). Patients with […]

The Fast-Changing World of CLL

Do you remember when CLL was managed largely with chlorambucil? The big decision was whether to give the agent daily or in pulses every two […]

Letter From the Editor: More CRO Fun

Last year, coming off the heels of an editorial by Mikkael Sekeres in ASH Clinical News, I wrote a piece for this column called “Take Back […]

Letter From the Editor: Mentoring

I have just returned from Scottsdale, Arizona, where I spent a day at the Lymphoma Research Foundation Clinical Research Mentoring Program (LCRMP). This four-day workshop is designed […]

Letter From the Editor: Trivia Night

Last night, my wife and I went to a fund-raiser for our local elementary school. The school, called North Glendale, is everything a public school should […]

Letter From the Editor: Another Plenary, More Uncertainty

I write this letter 5 days after the 2017 ASH annual meeting. The ASH meeting is always a highlight of the year for hematologists. It is […]

Letter From the Editor: Protests

I have been thinking about protests lately—largely in response to the NFL national anthem controversy, which has left me wondering about the most effective way to protest. […]